Evidence map›Paper›PMID 25070093›Full record

ArticleAntimicrobial agents and chemotherapy2014

Sigma S-dependent antioxidant defense protects stationary-phase Escherichia coli against the bactericidal antibiotic gentamicin.

Jing-Hung Wang, Rachna Singh, Michael Benoit, Mimi Keyhan, Matthew Sylvester, Michael Hsieh, Anuradha Thathireddy, Yi-Ju Hsieh, A C Matin

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Synergistic Microbicidal Effect of AUR and PEITC AgainstFrontiers in cellular and infection microbiology · 2022
    Article
  6. Article
  7. Sublethal Paraquat Confers Multidrug Tolerance inFrontiers in microbiology · 2020
    Article
  8. Article
  9. Superoxide dismutase activity confers (p)ppGpp-mediated antibiotic tolerance to stationary-phaseProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  10. Article
  11. Article
  12. RpoN PromotesFrontiers in microbiology · 2017
    Article
  13. Article
  14. Antibiotic efficacy is linked to bacterial cellular respiration.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jing-Hung WangDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
Rachna SinghDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
Michael BenoitDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
Mimi KeyhanDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
Matthew SylvesterDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
Michael HsiehDepartment of Urology, Stanford University School of Medicine, Stanford, California, USA.
Anuradha ThathireddyDepartment of Urology, Stanford University School of Medicine, Stanford, California, USA.
Yi-Ju HsiehDepartment of Urology, Stanford University School of Medicine, Stanford, California, USA.
A C MatinDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA a.matin@stanford.edu.
Stanford University · US

Funding

Estrogenic Modulation of Genitourinary Epithelial-Probiotic Cross-TalkK08DK087895 · NIDDK · STANFORD UNIVERSITY · PI HSIEH, MICHAEL HARRISON · 2010 to 2014
$902k
NIDDK NIH HHS DK087895NIDDK NIH HHS K08 DK087895
6 · The paper itself

Abstract

Stationary-phase bacteria are important in disease. The σ(s)-regulated general stress response helps them become resistant to disinfectants, but the role of σ(s) in bacterial antibiotic resistance has not been elucidated. Loss of σ(s) rendered stationary-phase Escherichia coli more sensitive to the bactericidal antibiotic gentamicin (Gm), and proteomic analysis suggested involvement of a weakened antioxidant defense. Use of the psfiA genetic reporter, 3'-(p-hydroxyphenyl) fluorescein (HPF) dye, and Amplex Red showed that Gm generated more reactive oxygen species (ROS) in the mutant. HPF measurements can be distorted by cell elongation, but Gm did not affect stationary-phase cell dimensions. Coadministration of the antioxidant N-acetyl cysteine (NAC) decreased drug lethality particularly in the mutant, as did Gm treatment under anaerobic conditions that prevent ROS formation. Greater oxidative stress, due to insufficient quenching of endogenous ROS and/or respiration-linked electron leakage, therefore contributed to the greater sensitivity of the mutant; infection by a uropathogenic strain in mice showed this to be the case also in vivo. Disruption of antioxidant defense by eliminating the quencher proteins, SodA/SodB and KatE/SodA, or the pentose phosphate pathway proteins, Zwf/Gnd and TalA, which provide NADPH for ROS decomposition, also generated greater oxidative stress and killing by Gm. Thus, besides its established mode of action, Gm also kills stationary-phase bacteria by generating oxidative stress, and targeting the antioxidant defense of E. coli can enhance its efficacy. Relevant aspects of the current controversy on the role of ROS in killing by bactericidal drugs of exponential-phase bacteria, which represent a different physiological state, are discussed.

Indexed as

AnimalsAnti-Bacterial AgentsAntioxidantsEscherichia coliFemaleGene Expression Regulation, BacterialGentamicinsMiceSigma FactorAnti-Bacterial AgentsAntioxidantsGentamicinsSigma Factor

Identifiers

PMID25070093
PMCPMC4187989
OpenAlexW2118497545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.